Nanomedicines for the treatment of hematological malignancies

Journal of Controlled Release : Official Journal of the Controlled Release Society
Anil K DeshantriMarcel H A M Fens

Abstract

Hematological malignancies (HM) are a collection of malignant transformations originating from cells in the primary or secondary lymphoid organs. Leukemia, lymphoma, and multiple myeloma comprise the three major types of HM. Current treatment consists of bone marrow transplantation, radiotherapy, immunotherapy and chemotherapy. Although, many chemotherapeutic drugs are clinically available for the treatment of HM, the use of these agents is limited due to dose-related toxicity and lack of specificity to tumor tissue. Moreover, the poor pharmacokinetic profile of most of the chemotherapeutics requires high dosage and frequent administration to maintain therapeutic levels at the target site, both increasing adverse effects. This underlines an urgent need for a suitable drug delivery system to improve efficacy, safety, and pharmacokinetic properties of conventional therapeutics. Nanomedicines have proven to enhance these properties for anticancer therapeutics. The most extensively studied nanomedicine systems are lipid-based nanoparticles and polymeric nanoparticles. Typically, nanomedicines are small sub-micron sized particles in the size range of 20-200 nm. The biocompatible and biodegradable nature of nanomedicines makes them a...Continue Reading

Citations

May 10, 2019·Artificial Cells, Nanomedicine, and Biotechnology·Guangping YuShengsong Tang
Nov 21, 2019·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Y N ZhaoS B Zhang
Apr 22, 2020·Biomaterials Science·Lifen HuangChun Chen
Nov 18, 2018·International Journal of Molecular Sciences·Dominika Hobernik, Matthias Bros
Sep 17, 2020·Biomedicines·Lavinia SalamaShaker A Mousa
Aug 28, 2020·Nature Communications·Raquel FerreiraLino Ferreira
Oct 9, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Wenxing GuZhiyuan Zhong
Mar 17, 2021·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Marian A Ackun-FarmmerBenjamin J Frisch
Nov 8, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Julian BejaranoMarcelo J Kogan
Jun 4, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Chenmala KarthikaMohamed M Abdel-Daim
Mar 25, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Wendi XiaoYucheng Zhong
Aug 15, 2021·DNA Repair·Sajjad Vakili-SamianiFarhad Jadidi-Niaragh
Aug 21, 2021·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Giancarlo FacchiniGiuseppe Rossi
Sep 4, 2021·Materials Science & Engineering. C, Materials for Biological Applications·Prathapan AbeeshChandrasekharan Guruvayoorappan
Oct 14, 2021·Molecular Biology Reports·Huihui JiangChengming Sun

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here